River Stone Biotech ApS: Financial statements 2018
CVR: 39126729
Source: annual report 2018, Danish Business Authority
30/11/2017 – 31/12/2018
River Stone Biotech ApS (CVR 39126729) has filed annual accounts for 2018. In 2018, the company reported a net result of DKK -11,103,388. Equity in the 2018 report amounted to DKK -11,053,388. The company had 11 employees in the financial year.
- Profit/Loss
- DKK -11,103,388
- Equity
- DKK -11,053,388
- Total Assets
- DKK 8,699,501
- Employees
- 11
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of December 21, 2018, Jørgen Hansen has joined the board of directors of River Stone Biotech ApS.
As of December 21, 2018, Paul D. Goldenheim has joined the board of directors of River Stone Biotech ApS.
As of December 21, 2018, Jørgen Hansen is registered as adm. dir. of River Stone Biotech ApS.
As of December 21, 2018, Paul D. Goldenheim has stepped down as director of River Stone Biotech ApS.
About River Stone Biotech ApS
River Stone Biotech ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jørgen Hansen. The board consists of Jørgen Hansen and Paul D. Goldenheim. The company is owned by River Stone Biotech Inc.. The company has 32 employees (2026). In 2025, the company reported a gross profit of DKK 1,169,131 and a net result of DKK -31,204,765 compared with DKK -44,572,973 the year before. Equity in the 2025 report amounted to DKK 7,827,761.